RSV vaccination in older adults: Addressing vaccine hesitancy using the 3C model.

ABSTRACT: The first vaccine against respiratory syncytial virus (RSV) targeting older adults was approved for use in Canada in August 2023. As a frequent first point of contact for Canadians seeking advice on vaccination and the most common setting for the administration of influenza vaccines, community pharmacies will also play a role in RSV vaccination efforts. To address vaccine hesitancy confidently and effectively, pharmacists must be equipped with knowledge of the factors that affect a person's decision on whether to be vaccinated or not. The 3C Model of Vaccine Hesitancy summarizes these as complacency, confidence and convenience. This article introduces the model and describes the often-underrecognized relevance of RSV to older adults, including risk factors and burden of disease. It also re

SUBMITTER: Houle SKD 

PROVIDER: S-EPMC10729719 | biostudies-literature | 2024 Jan-Feb

REPOSITORIES: biostudies-literature